Global Internal Neuromodulation Devices Market is Growing at a Significant Rate in the Forecast Period 2018-2025

According to Data Bridge Market Research new Market report, “Global Internal Neuromodulation Devices Market By Product Type (Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Indication of Usage (Failed Back Surgery Syndrome, Conditional Regional Pain Syndrome, Eschemia, Parkinson’s Disease, Alzheimers, Urinary Incontinence, Faecal Incontinenece, Epilepsy, Gastroparesis, Others), By Lead Type (Percutaneous, Paddle Lead), By Battery Type (Primary, Rechargeable), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast is projected to reach USD 14.72 billion by 2025, at a CAGR of 15.2% during the forecast period of 2018 to 2025.

Access Full Report: https://databridgemarketresearch.com/reports/global-internal-neuromodulation-devices-market/

Global Internal Neuromodulation Devices Market

Neuromodulation is a technology, which is used to stimulate specific neurological sites or alteration of the nerve activity by using electricity or chemical agents in the body. Most of these devices use electric stimulations. The device is mostly used to treat people suffering from conditions such as tremor, chronic pain, fecal and urinary incontinence, dystonia Parkinson’s disease, epilepsy, and other psychological disorders.

In April 2013 boston scientific, launched its Precision Spectra device, pain-relief technology Precision Spectra is used for the treatment of chronic back pain.

In February 2015, Cyberonics and Sorin group merged and created a new premier global medical technology company. The proposed alliance brought both the global leaders in cardiac surgery and neuromodulation, and the combined company will also be a major player in cardiac rhythm management, especially in Europe and Japan.

In May 2018, StimGuard LLC, received CE Mark approval for the world’s first wireless programmable neuromodulation device. This device can be introduced through a needle without surgery for treating chronic, intractable symptoms of overactive bladder.

All these technological advancements to treat neurological disorders are showing an optimistic rate of growth in future.

Segmentation: Global Internal Neuromodulation Devices Market

The global market for internal neuromodulation devices by the following sub-categories is presented

  • By Product Type

    • Spinal Cord Stimulator
    • Deep Brain Stimulator
    • Vagus Nerve Stimulator
    • Sacral Nerve Stimulator
    • Gastric Nerve Stimulator

  • By Indication of Usage

    • Failed Back Surgery Syndrome
    • Conditional Regional Pain Syndrome
    • Eschemia
    • Parkinson’s Disease
    • Alzheimers
    • Urinary Incontinence
    • Faecal Incontinenece
    • Epilepsy
    • Gastroparesis
    • Others

  • By Lead Type

    • Percutaneous
    • Paddle Lead

  • By Battery Type

    • Primary
    • Rechargeable

  • By Geography

    • North America
    • South America
    • Europe
    • Asia-Pacific
    • Middle East and Africa

FACTORS DRIVING GROWTH OF THE GLOBAL INTERNAL NEUROMODULATION DEVICES MARKET

Increasing Prevalence of Neurological Diseases:

According to the Alzheimer's Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. According to Alzheimer disease international, in 2015 there were an estimated 46.8 million people living with Alzheimer worldwide this number is expected to be double every 20 years reaching 75 million in 2030 and 131.5 million by 2050.

According to national center for biotechnology information, about 60,000 Americans are diagnosed with Parkinson’s every year. An estimated 7 million to 10 million people worldwide have Parkinson’s disease. The prevalence of this disease is 1,900 per 100,000 in those who are above 80 years of age and 41 per 100,000 in fourth decade of life.

Epilepsy is the chronic disorder of the brain which affects almost all ages. According to world health organization, 50 million people worldwide have epilepsy and this number is estimated to increase in coming years which makes it one of the most common neurological disorders.

Therefore, with the increase in disease condition such as Alzheimer’s, Parkinson’s, epilepsy, eschemia, the global internal neuromodulation devices market is expected to achieve a growth in future.

Medtronic, Boston Scientific Corporation, Abbott, Nevro Corp, Cyberonics, Inc., Neuros Medical, Inspire Medical Systems, Inc, SPR Therapeutics, Synapse Biomedical Inc, NeuroSigma, Inc, NeuroPace, Inc., Neuronetics., BioControl Medical, Soterix Medical Inc, DynaMD, Integer Holdings Corporation, LivaNova PLC, Bioness Inc, ReShape Lifesciences, Inc,.

Browse Related Reports:      

North America Electroencephalography Devices Market,By Product Type, By End User, By Country (U.S., Canada, Mexico) –Industry Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/north-america-electroencephalography-devices-market/

Global Hydronephrosis Market By Type (Unilateral, Bilateral), Diagnosis (Imaging, Laboratory Tests), Treatment (Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Others), Indication (Intrinsic, Extrinsic), End user, Geography- Industry Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/global-hydronephrosis-market/

Europe Nerve Regeneration and Repair Market, By Type (Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Neurostimalation (Internal (SCS, DBS, VNS, SNS, GES), External (TENS, TMS, RES))), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair (Epineural, Perineural, Group Fascicular Repair), Grafting (Autograft, Allograft, Xenograft)), By End-User (Hospitals, Neurology Clinics, Home Healthcare, Community Healthcare), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/europe-nerve-repair-and-regeneration-market/

Global Interventional Neurology Devices Market, By Product {(Aneurysm Coiling and Embolization Devices (Embolic Coils, Flow Diversion Devices, Liquid Embolic Devices), Angioplasty Devices (Carotid Artery Stents, Embolic Protection Systems), Micro Support Devices (Microguidewires, Microcatheters), Neurothrombectomy Devices (CLOT Retrieval Devices, Suction and Aspiration Devices, Snares)},Procedure (Embolization, Angioplasty,Neurothrombectomy, Others), End-User (Hospitals, Neurology Clinics, Ambulatory Care Centers, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America) – Industry Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/global-interventional-neurology-devices-market/